Form 8-K

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

July 31, 2003

Date of Report

(Date of earliest event reported)

 

RITA Medical Systems, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of incorporation)

 

000-30959   94-3199149
(Commission File Number)   (I.R.S. Employer Identification No.)

 

967 N. Shoreline Blvd.

Mountain View, CA 94043

(Address of principal executive offices, with zip code)

 

(650) 314-3400

(Registrant’s telephone number, including area code)

 



Item 9.   Regulation FD Disclosure.

 

On July 29, 2003, RITA Medical Systems, Inc., a Delaware corporation (“RITA”), announced it had hired Joseph M. DeVivo as President and Chief Executive Officer. A copy of RITA’s press release announcing this addition to the Company’s management is attached as Exhibit 99.1 hereto and incorporated by reference herein.

 


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     RITA Medical Systems, Inc.
Date: July 31, 2003    By:   

/s/    Donald Stewart


Donald Stewart, Chief Financial Officer and

Vice President Finance and Administration